Pharmarise Holdings Income Statement

Financials in millions JPY. Fiscal year is June - May.

Millions JPY. Fiscal year is Jun - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021
Revenue	66,566	63,508	54,466	52,030	51,608	52,324
Revenue Growth (YoY)	14.65%	16.60%	4.68%	0.82%	-1.37%	2.54%
Cost of Revenue	57,285	54,542	46,017	43,896	43,491	44,256
Gross Profit	9,281	8,966	8,449	8,134	8,117	8,068
Selling, General & Admin	4,877	4,860	4,371	3,728	3,525	3,659
Amortization of Goodwill & Intangibles	763	763	557	635	700	738
Other Operating Expenses	3,048	3,048	2,605	2,332	2,371	2,417
Operating Expenses	8,661	8,671	7,533	6,695	6,596	6,821
Operating Income	620	295	916	1,439	1,521	1,247
Interest Expense	-233	-178	-66	-55	-65	-75
Interest & Investment Income	9	10	1	2	2	2
Other Non Operating Income (Expenses)	65	-10	-19	44	58	54
EBT Excluding Unusual Items	461	117	832	1,430	1,516	1,228
Gain (Loss) on Sale of Investments	-	7	19	30	-	-4
Gain (Loss) on Sale of Assets	20	20	-1	-4	2	61
Asset Writedown	-224	-258	-296	-393	-218	-51
Other Unusual Items	85	124	-411	-14	21	-32
Pretax Income	342	10	143	1,049	1,321	1,202
Income Tax Expense	495	390	485	702	864	782
Earnings From Continuing Operations	-153	-380	-342	347	457	420
Minority Interest in Earnings	10	13	-9	-14	-10	6
Net Income	-143	-367	-351	333	447	426
Net Income to Common	-143	-367	-351	333	447	426
Net Income Growth	-	-	-	-25.50%	4.93%	-26.17%
Shares Outstanding (Basic)	11	11	11	9	9	9
Shares Outstanding (Diluted)	11	11	11	12	12	12
Shares Change (YoY)	0.52%	7.58%	-15.61%	0.59%	0.20%	-1.03%
EPS (Basic)	-12.56	-32.42	-33.35	35.42	47.90	45.78
EPS (Diluted)	-12.56	-32.42	-33.35	26.86	36.22	34.59
EPS Growth	-	-	-	-25.83%	4.70%	-25.31%
Free Cash Flow	611	674	2,242	2,140	334	1,437
Free Cash Flow Per Share	53.67	59.53	213.04	171.61	26.94	116.15
Dividend Per Share	14.000	14.000	14.000	14.000	14.000	14.000
Gross Margin	13.94%	14.12%	15.51%	15.63%	15.73%	15.42%
Operating Margin	0.93%	0.46%	1.68%	2.77%	2.95%	2.38%
Profit Margin	-0.21%	-0.58%	-0.64%	0.64%	0.87%	0.81%
Free Cash Flow Margin	0.92%	1.06%	4.12%	4.11%	0.65%	2.75%
EBITDA	2,176	1,788	2,086	2,663	2,829	2,591
EBITDA Margin	3.27%	2.81%	3.83%	5.12%	5.48%	4.95%
D&A For EBITDA	1,556	1,493	1,170	1,224	1,308	1,344
EBIT	620	295	916	1,439	1,521	1,247
EBIT Margin	0.93%	0.46%	1.68%	2.77%	2.95%	2.38%
Effective Tax Rate	144.74%	3900.00%	339.16%	66.92%	65.41%	65.06%

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.